Gene · 7185
Papers2,530
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,530
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Causal relationship between rheumatoid arthritis and hypothyroidism or hyperthyroidism: a bidirectional two-sample univariable and multivariable Mendelian randomization study. | Front Endocrinol (Lausanne) | 2023 | 38093966 | PubTator, text mining | PubMed |
| Effects of RNA methylation on Tumor angiogenesis and cancer progression. | Mol Cancer | 2023 | 38053093 | PubTator, text mining | PubMed |
| Integrated systems biology approach identifies gene targets for endothelial dysfunction. | Mol Syst Biol | 2023 | 38031960 | PubTator, text mining | PubMed |
| Cathepsin W, T-cell receptor-associated transmembrane adapter 1, lymphotactin and killer cell lectin like receptor K1 are sensitive and specific RNA biomarkers of canine epitheliotropic lymphoma. | Front Vet Sci | 2023 | 38026637 | PubTator, text mining | PubMed |
| Identification of a regulatory pathway governing TRAF1 via an arthritis-associated non-coding variant. | Cell Genom | 2023 | 38020975 | PubTator, text mining | PubMed |
| Fn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling. | Front Cell Dev Biol | 2023 | 38020877 | PubTator, text mining | PubMed |
| Characterization of target gene regulation by the two Epstein-Barr virus oncogene LMP1 domains essential for B-cell transformation. | mBio | 2023 | 38009935 | PubTator, text mining | PubMed |
| Structural Characterization of TRAF6 N-Terminal for Therapeutic Uses and Computational Studies on New Derivatives. | Pharmaceuticals (Basel) | 2023 | 38004473 | PubTator, text mining | PubMed |
| Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas. | Cells | 2023 | 37998391 | PubTator, text mining | PubMed |
| ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma. | Mol Cancer | 2023 | 37980532 | PubTator, text mining | PubMed |
| New insights into the genetic predisposition of brucellosis and its effect on the gut and vaginal microbiota in goats. | Sci Rep | 2023 | 37973848 | PubTator, text mining | PubMed |
| Aging-related genes revealed Neuroinflammatory mechanisms in ischemic stroke by bioinformatics. | Heliyon | 2023 | 37954339 | PubTator, text mining | PubMed |
| Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies. | Front Oncol | 2023 | 37954086 | PubTator, text mining | PubMed |
| The genes regulating sensitivity of tumor cells to T cell-mediated killing: could they be potential personalized immunotherapeutic targets in head and neck squamous cell carcinoma? | Discov Oncol | 2023 | 37926766 | PubTator, text mining | PubMed |
| The Role of ncRNAs in the Immune Dysregulation of Preeclampsia. | Int J Mol Sci | 2023 | 37894897 | PubTator, text mining | PubMed |
| The RELT Family of Proteins: An Increasing Awareness of Their Importance for Cancer, the Immune System, and Development. | Biomedicines | 2023 | 37893069 | PubTator, text mining | PubMed |
| Unraveling the relationship between the renin-angiotensin system and endometrial cancer: a comprehensive review. | Front Oncol | 2023 | 37869088 | PubTator, text mining | PubMed |
| N6-methyladenosine methylation in kidney injury. | Clin Epigenetics | 2023 | 37865763 | PubTator, text mining | PubMed |
| Targeting the NLRP3 inflammasome and associated cytokines in scleroderma associated interstitial lung disease. | Front Cell Dev Biol | 2023 | 37849737 | PubTator, text mining | PubMed |
| Circular RNAs are associated with the resistance to Newcastle disease virus infection in duck cells. | Front Vet Sci | 2023 | 37841466 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7185/papers?page=7